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Abstract
It has been postulated that mucus stasis is central to the pathogenesis of obstructive lung diseases. 
In Scnn1b-transgenic (Scnn1b-Tg+) mice, airway-targeted overexpression of the epithelial Na+ 
channel β subunit causes airway surface dehydration, which results in mucus stasis and 
inflammation. Bronchoalveolar lavage from neonatal Scnn1b-Tg+ mice, but not wild-type 
littermates, contained increased mucus, bacteria, and neutrophils, which declined with age. 
Scnn1b-Tg+ mice lung bacterial flora included environmental and oropharyngeal species, 
suggesting inhalation and/or aspiration as routes of entry. Genetic deletion of the Toll/
Interleukin-1 receptor adapter molecule MyD88 in Scnn1b-Tg+ mice did not modify airway mucus 
obstruction, but caused defective neutrophil recruitment and increased bacterial infection, which 
persisted into adulthood. Scnn1b-Tg+ mice derived into germ-free conditions exhibited mucus 
obstruction similar to conventional Scnn1b-Tg+ mice and sterile inflammation. Collectively, these 
data suggest that dehydration-induced mucus stasis promotes infection, compounds defects in 
other immune mechanisms, and alone is sufficient to trigger airway inflammation.
INTRODUCTION
Respiratory health is maintained by an integrated network of innate and adaptive defense 
mechanisms. At the airway surface, mechanical mucus clearance is largely responsible for 
efficient removal of noxious stimuli, and mucus stasis has been suggested to produce airway 
lung diseases, including cystic fibrosis (CF), primary ciliary dyskinesia (PCD), and chronic 
obstructive pulmonary disease (COPD). Effective mucus clearance relies upon multiple 
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processes, e.g., epithelial ion and water transport, mucin secretion, ciliary beat, phasic 
airway motion, and cough 1. Experimentally, mucus stasis has been achieved in mice by 
airway-targeted overexpression of the epithelial Na+ channel β subunit (βENaC, encoded by 
the Scnn1b gene) 2. In Scnn1b-transgenic (Scnn1b-Tg+) mice, airway epithelial Na+ 
hyperabsorption causes a depletion of airway surface liquid and an increase in mucus 
concentration 2, which is predicted to impair mucus clearance. Indeed, Scnn1b-Tg+ mice 
exhibit mucus stasis and airway inflammation, which emerges in the neonatal period and 
produces a pathology resembling human CF/chronic bronchitis 2,3.
Although Scnn1b-Tg+ mice exhibit delayed clearance of instilled bacteria 2 and chronic 
neutrophilic inflammation 3, the initial studies failed to detect spontaneous bacterial 
infection, a hallmark of CF lung disease 4 and an important component of COPD 
exacerbations 5. This observation suggested that mucus stasis could produce inflammation 
without infection, i.e., sterile inflammation. However, the original microbiological studies 
were conducted only in adult mice and did not take into account the role of normal 
developmental processes, including maturation of innate and adaptive immunity 6,7 and 
transient abundance of mucous secretory cells 8,9, which likely play a role in the evolution 
of lung pathology in Scnn1b-Tg+ mice. Moreover, static airway mucus creates a 
microaerophilic/hypoxic environment 10, which may favor the growth of bacterial species 
not detectable in the conventional aerobic bacterial cultures performed in the original studies 
of Scnn1b-Tg+ mice.
Accordingly, we initiated a series of longitudinal studies designed to explore the interactions 
between mucus clearance and host defense in Scnn1b-Tg+ mice. First, we tested the 
hypothesis that neonatal Scnn1b-Tg+ mice are more susceptible to spontaneous bacterial 
infection than adult mice, due to the combination of defective mucus clearance, likely 
compounded by the transient increase in mucin production that occurs in the early postnatal 
period 8, and immature immune defenses. Thus, we measured bacterial colony forming units 
(CFUs) in bronchoalveolar lavage (BAL) as a function of age utilizing bacterial culture 
conditions that permitted detection of non-fastidious aerobes and microaerophilic bacteria. 
Second, we hypothesized that mechanical mucus clearance interacts with other 
developmentally regulated cellular defense mechanisms, e.g., Toll-like receptors 
(TLRs) 11,12, which could trigger airway inflammation in response to noxious stimuli 
accumulating in static mucus. Thus, we longitudinally evaluated whether components of 
Scnn1b-Tg+ lung pathogenesis were dependent on Toll/Interleukin-1 receptor domain 
adapter protein myeloid differentiation factor 88 (MyD88), which mediates signaling 
through several TLRs 13 and is critical for early post-natal immunity 14,15. Finally, to test 
whether live bacteria were necessary to trigger pulmonary inflammation due to airway 
surface dehydration and mucus stasis, we generated germ-free Scnn1b-Tg+ mice and 
characterized their lung phenotype.
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Scnn1b-Tg+ mice routinely exhibit spontaneous bacterial infection during the neonatal 
period but are inflamed throughout life
The first goal of this study was to determine whether airway surface dehydration and mucus 
stasis promoted spontaneous bacterial infection in Scnn1b-Tg+ mice. Longitudinal analysis 
of BAL from congenic C57BL6/N Scnn1b-Tg+ and wild-type (WT) littermates revealed no 
culturable bacteria in WT mice, whereas the majority of Scnn1b-Tg+ pups harbored 
intrapulmonary bacteria (Figure 1a). As Scnn1b-Tg+ mice aged, both the proportion of 
infected mice and the number of bacterial colony forming units (CFU) decreased.
Morphologically distinct bacterial colonies recovered from Scnn1b-Tg+ mice were identified 
by ribosomal 16S gene sequencing (Figure 1b). Scnn1b-Tg+ neonatal lung microflora 
included both Gram positive (mainly Streptococcus species and to lesser extent 
Staphylococcus xylosus, and Rothia nasimurium) and Gram negative bacteria (mainly 
Pasturella pneumotropica and Actinobacillus muris). Similar bacterial species were present 
in tissue homogenates of tongue and esophagus from 5 day-old mice, with no clear 
distinction between WT or Scnn1b-Tg+ mice (Figure 1c, tongue and esophagus), whereas 
these bacteria were frequently detected in tracheal homogenates from 5 day-old Scnn1b-Tg+ 
mice as compared to WT littermates (Figure 1c, trachea). The composition of the lung 
microflora in adult Scnn1b-Tg+ mice differed from younger mice, featuring low levels of 
Gram positive bacteria, e.g., Bacillus clausii and Bacillus pumilus at 1 month and 
Streptomyces and Staphylococcus lentus at 7 months of age (Figure 1b), suggesting a 
process of selection/adaptation.
Longitudinal analysis of BAL inflammatory markers indicated that Scnn1b-Tg+ mice 
exhibited an increased inflammatory infiltrate, predominantly neutrophilic, as compared to 
WT littermates at all ages (Figure 2). The relative increases in BAL neutrophils, KC and 
TNFα were more robust in neonatal mice (Figure 2b,e,f) when bacterial burden was highest. 
In contrast, the number of BAL macrophages and lymphocytes in the Scnn1b-Tg+ mice 
increased with age (Figure 2a,d), and eosinophils peaked at 4–8 wks (Figure 2c). 
Macrophages were morphologically activated in both neonatal (5 day-old) and adult (4 
week-old) Scnn1b-Tg+ mice, as indicated by higher incidence of enlarged macrophages 
compared to WT littermates (Figure 2g,h).
Ablation of MyD88 signaling in Scnn1b-Tg+ mice causes defective neutrophil recruitment 
and higher lung bacterial burden, but does not affect airway mucus obstruction
The temporal pattern of infection in Scnn1b-Tg+ mice suggests the interaction of airway 
mucus clearance with other developmentally regulated innate immune components, e.g., 
MyD88-dependent TLR signaling. To test this hypothesis, we generated Scnn1b-Tg+ and 
WT littermates (for this cross, referred to as Scnn1b-Tg-) that were either MyD88-sufficient 
(MyD88+/−) or MyD88-deficient (MyD88−/−). When raised under controlled husbandry 
conditions (see Methods), survival of all Scnn1b-Tg+ mice ranged between 75–100% 
(Figure 3a), reflecting the favorable effect of the C57Bl/6N genetic background 8 compared 
to the original C3H:C57 background, which had ~ 50% survival 2. Importantly, survival of 
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MyD88−/−;Scnn1b-Tg+ mice was significantly lower than MyD88+/−;Scnn1b-Tg+ or the 
other genotypes (ANOVA, p = 0.004), indicating that combined Scnn1b transgene 
overexpression and MyD88 homozygous deletion had a detrimental effect.
Microscopic analysis of BAL cytospin preparations revealed rod- and cocci-shaped bacteria 
in association with mucus plugs in neonatal MyD88−/−;Scnn1b-Tg+ mice, which were never 
observed in MyD88+/−;Scnn1b-Tg+ mice, despite similar mucus plugs (Figure 3b). 
Quantification of bacterial burden revealed that MyD88−/−;Scnn1b-Tg+ mice harbored 
significantly more bacteria than MyD88+/−;Scnn1b-Tg+ mice at all time points, and infection 
persisted into adulthood, although its severity decreased with age (Figure 3c). In particular, 
heterozygosity for MyD88 was sufficient to protect mice not carrying the Scnn1b transgene 
(MyD88+/−;Scnn1b-Tg-) from spontaneous bacterial infection. Conversely, complete 
MyD88 deficiency (MyD88−/−;Scnn1b-Tg-) led to significant bacterial burden in neonatal 
mice, which decreased at post-natal day (PND) 8–10 and was undetectable in adult mice. In 
agreement with the data presented in Figure 1a, bacteria were present in BAL of all neonatal 
MyD88+/−;Scnn1b-Tg+ mice, and were sporadically detected in adult mice.
The lung microflora of colonized mice from the MyD88−/− × Scnn1b-Tg+ cross (Figure 3d) 
was also more diverse than in C57BL/6N Scnn1b-Tg+ mice (Figure 1b). Streptococcus and 
Klebsiella species were prevalent, and Staphylococcus, Proteus, Enterococcus, and Rothia 
species were frequently detected but at lower density (Figure 3d). Of note, Streptococcus, 
Klebsiella, Staphylococcus and Enterococcus species persisted in MyD88−/−;Scnn1b-Tg+ 
mice throughout adulthood.
A longitudinal analysis of BAL cell counts and inflammatory mediators was performed to 
assess the contribution of MyD88 signaling to lung inflammation. Notably, BAL neutrophil 
counts were lower in MyD88−/−;Scnn1b-Tg+ versus MyD88+/−;Scnn1b-Tg+ mice at all time 
points (Figure 4b). Macrophages constituted the predominant cell population in MyD88+/− 
and MyD88−/− mice not carrying the Scnn1b transgene (Figure 4a). Except for PND 10, 
when macrophages were increased, Myd88−/−;Scnn1b-Tg+ mice exhibited macrophage 
numbers (Figure 4a) and morphological activation (Figure 4e) similar to Myd88+/−;Scnn1b-
Tg+ mice. Absence of MyD88 also reduced BAL eosinophils in 10 day-old Scnn1b-Tg+ 
mice and prevented the transient developmental eosinophilia in Scnn1b-Tg− mice 8 (Figure 
4c). Finally, BAL lymphocytes were sharply increased in Myd88−/−;Scnn1b-Tg+ mice at 
PND 10, but waned afterwards (Figure 4d).
The inflammatory mediator profile of cell-free BAL (Figure 5) mirrored the changes in BAL 
cell composition. Myd88−/−;Scnn1b-Tg+ mice exhibited reduced neutrophil 
chemoattractants (KC, LIX, MIP-2), granulocyte differentiation factors (G-CSF), and TNFα 
at PND 5 compared to Myd88+/−;Scnn1b-Tg+ mice. Macrophage colony stimulating factor 
(M-CSF) was higher at PND 10 in Myd88−/−;Scnn1b-Tg+ mice, paralleling higher BAL 
macrophages at this time point. MIP-1α, IL-6, GM-CSF, IL-1α, IL-1β, and MCP-1 were 
either at or below the lower limit of detection, and differences among groups failed to be 
significant or exhibit consistent trends (data not shown).
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A longitudinal histological analysis was performed to test whether MyD88 deficiency 
modified the lung pathology in Scnn1b-Tg+ mice (Figure 6). Absence of MyD88 did not 
alter the transient abundance of tracheal and bronchial mucous secretory cells normally 
observed postnatally 8,9 (Figure 6a,b). Myd88+/−;Scnn1b-Tg+ and Myd88−/−;Scnn1b-Tg+ 
mice exhibited comparable tracheal mucus plugging and mucous secretory cells in neonates 
(Figure 6a), a similar progression of mucus obstruction (from trachea to bronchi, Figure 
6a,c), and equivalent air space enlargement (data not shown). However, 8 week-old 
Myd88−/−;Scnn1b-Tg+ mice had significantly more lymphoid aggregates than 
Myd88+/−;Scnn1b-Tg+ mice (Figure 6d), suggesting a response to a greater bacterial burden 
and/or alteration of adaptive immune responses.
Germ-free Scnn1b-Tg+ mice are devoid of bacteria, but still develop mucus obstructive 
lung disease
To define the relative contributions of dehydrated mucus vs. neonatal bacterial infection to 
the development of obstructive airways disease, we derived Scnn1b-Tg+ mice in a germ-free 
(GF) environment. As expected, BAL from GF Scnn1b-Tg+ mice harvested at PND 5, when 
both incidence of infection and bacterial load are maximal in SPF Scnn1b-Tg+ mice, was 
sterile (n=5). Adult GF Scnn1b-Tg+ mice exhibited overt airway mucus obstruction and, 
strikingly, persistent inflammation (Figure 7a–c). Indeed, the overall lung pathology, as 
assessed by semi-quantitative histology score, was comparable in GF and SPF Scnn1b-Tg+ 
mice, at both 10 days and 4 weeks of age (Figure 7d).
BAL longitudinal analysis revealed that 5–10 day-old GF Scnn1b-Tg+ mice had more 
macrophages than their WT littermates (Figure 7e), which was not a feature of SPF Scnn1b-
Tg+ mice (Figure 2a). Although macrophage number in adult GF Scnn1b-Tg+ mice 
normalized towards WT levels, GF Scnn1b-Tg+ macrophages remained morphologically 
activated (Figure 7i). GF Scnn1b-Tg+ mice had higher neutrophil counts compared to WT 
littermates at all time points (Figure 7f) and more eosinophils and lymphocytes in adult mice 
(Figure 7g-h). Of note, BAL neutrophil counts were lower in neonatal GF Scnn1b-Tg+ mice 
compared to SPF Scnn1b-Tg+ mice (87 ± 18×103 vs. 269 ± 71×103 for GF and SPF 10 day-
old mice, respectively, p<0.05), but did not differ in adult mice. As in the SPF environment, 
the BAL cytokine profile of GF Scnn1b-Tg+ mice was characterized by elevated neutrophil-
related mediators (KC, LIX, and G-CSF), whereas, unlike SPF Scnn1b-Tg+ mice, TNFα was 
not elevated compared to WT littermates (Figure 8a).
Because sterilized feed and bedding in GF conditions are not free of bacterial products, we 
tested whether environmental LPS, trapped after inhalation by static airway mucus, could be 
responsible for stimulating inflammation in GF Scnn1b-Tg+ mice. As expected, the level of 
LPS in unfractionated BAL from 5 day-old SPF Scnn1b-Tg+ was significantly higher than in 
WT littermates, but LPS was barely detectable and equivalent in GF Scnn1b-Tg+ mice and 
WT littermates (Figure 8b). Thus, the inflammation observed in GF Scnn1b-Tg+ mice 
appears to be independent of both live bacteria and at least one major bacterial product 
(LPS).
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In the respiratory tract, effective host defense depends primarily upon rapid mechanical 
clearance of inhaled noxious agents 16. The paradigm that defective mucus clearance favors 
bacterial infections of the airways is widely accepted 1, but has never been rigorously tested, 
nor has the interplay between mucus clearance and other innate defense mechanisms been 
explored. We used an in vivo model of abnormal mucus clearance, i.e., the Scnn1b-Tg+ 
mouse, to explore the mechanisms involved in acquisition versus protection from airway 
bacterial infections.
Spontaneous bacterial infections are rarely reported in mouse models and usually occur in 
immunocompromized strains 17–19. Our longitudinal studies indicate that defective mucus 
clearance caused a breach in host defense resulting in an age-dependent presence of bacteria 
in the lungs (Figure 1a). This presence likely constitutes an “infection”, as indicated by 
higher neutrophils and TNFα in BAL from SPF Scnn1b-Tg+ mice (Figure 2b,f) compared to 
GF Scnn1b-Tg+ mice which have similar mucus obstruction but no bacteria (Figures 7f and 
8a). As occurs in CF 10, the infection in Scnn1b-Tg+ mice appears to be centered on the 
airways (Figure 1c, trachea, and Figure 3b, airway mucus). We speculate that the bacterial 
density (103/lung) likely reprises that observed in human muco-obstructive airway 
infections. Specifically, we estimated that the mucus volume in neonatal Scnn1b-Tg+ mice is 
~ 1 μl (see Methods), producing a density of 106 bacteria/ml, a value typical for sputum 
samples in CF subjects 20.
The decrease in lung bacterial burden as Scnn1b-Tg+ mice aged is likely due to the postnatal 
maturation of innate 21 and adaptive 7 immunity, including changes in pattern recognition 
receptor expression 11,12, neutrophils 22 and antigen presenting cell functions 23, as well as 
changes in airway mucous secretory cell number/secretions 8,9,24,25. Moreover, in mouse 
airways the density of airway ciliated cells increases with age 26 and maximal mucus 
transport rates are generated after PND 9 27, partially offsetting the clearance defect due to 
mucus dehydration in Scnn1b-Tg+ mice.
The bacterial species most prevalent in the lungs of Scnn1b-Tg+ mice during the neonatal 
period also populated the mouse tongue and esophagus (Figure 1c), suggesting the 
oropharynx as the portal of entry. We speculate that while aspiration occurred in both WT 
and Scnn1b-Tg+ mice, infection selectively affected Scnn1b-Tg+ mice due to the poor 
clearance of aspirated contents. CF patients also exhibit concordant bacterial genotypes in 
the upper and lower airways 28–30, indicating aspiration as a likely mechanism of spread in 
human diseases associated with pulmonary mucus stasis.
The shift in bacterial species between neonatal and adult Scnn1b-Tg+ mice may indicate 
that, after clearing the initial infection, Scnn1b-Tg+ mice became susceptible to intermittent 
infection with species already present in the cage and/or oral environment. Alternatively, 
bacterial competition in the mucus niche may have favored the species recovered in older 
mice. Regardless, these data highlight a feature of this model which should be helpful for 
studying the longitudinal pathogenesis of chronic lung diseases characterized by persistent/
recurrent bacterial infection 31.
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Certain caveats apply to our microbiologic studies. First, mice housed in SPF facilities are 
not exposed to highly infectious murine pathogens, which may be more successful in 
establishing persistent infection in Scnn1b-Tg+ mice. Second, BAL sampling might have not 
harvested all bacteria, but it was preferred over lung homogenization which was found to 
inhibit growth of the isolated species. Third, bacterial detection was limited to species 
capable of growth under the specific culture conditions used, which were not permissive for 
strict anaerobes and fastidious aerobes. Future studies should focus on exposure to selected 
pathogens and more sophisticated culture-independent methods suitable to detect small 
numbers of bacteria, i.e., emulsion PCR and 454 pyrosequencing.
Our studies also demonstrated that other mucosal defense mechanisms modulate the 
response to airway bacterial infection due to defective mucus clearance. Studies designed to 
identify ancillary protective mechanisms revealed that MyD88-dependent innate immunity 
is key in determining the severity of airway bacterial infections in Scnn1b-Tg mice. In 
neonatal mice, MyD88 deficiency in the absence of mucus stasis (MyD88−/−;Scnn1b-Tg− 
mice) produced bacterial burdens comparable to those caused by mucus obstruction alone 
(MyD88+/−;Scnn1b-Tg+ mice) (Figure 3c), whereas the presence of both MyD88 deficiency 
and mucus stasis (MyD88−/−;Scnn1b-Tg+ mice) produced an additive effect, suggesting that 
the two defense mechanisms operate independently. Of note, the greater bacterial burden in 
neonatal MyD88−/−;Scnn1b-Tg+ mice compared to MyD88+/−;Scnn1b-Tg+ mice was not 
associated with increased mucus obstruction or mucous secretory cells (Figure 6a–c), 
indicating that MyD88 deletion predominantly affected the immune functions of 
inflammatory 32 and epithelial cells 33.
The sensitivity of MyD88−/− mice to bacterial infection differs depending on the 
microorganism studied 34, but is generally regarded as “broad”. MyD88 deletion prevents 
signaling through TLR 1, 2, 4, 5, 7, and 9 and blunts immune responses by impairing 
neutrophil chemotaxis (Figure 4b) and secretion of inflammatory mediators, such as KC, 
MIP-2, CXCL5/LIX (Figure 5). However, both MyD88−/−;Scnn1b-Tg− mice and 
MyD88−/−;Scnn1b-Tg+ mice exhibited reduced bacterial burdens as a function of age 
(Figure 3c), indicating the maturation of MyD88-independent protective 
mechanisms 13,16,35–37. Nonetheless, the higher and persistent bacterial burden in adult 
MyD88−/−;Scnn1b-Tg+ mice suggests that the MyD88-independent mechanisms were 
insufficient to completely overcome two additive defects in mucosal defense.
The studies described above highlight the complex interplay between mucus obstruction, 
infection, and inflammation in our model. The persistence of lung neutrophilia in adult 
Scnn1b-Tg+ mice (Figure 2b) could reflect the presence of non-culturable bacteria. 
Alternatively, airway mucus stasis per se could contribute to the inflammatory response 
observed in muco-obstructive lung diseases by impairing clearance of noxious stimuli. To 
distinguish between these two hypotheses, we generated GF Scnn1b-Tg+ mice, which were 
reared in a low-endotoxin environment (Figure 8b). Notably, adult GF Scnn1b-Tg+ mice 
exhibited lung inflammation and histopathology comparable to SPF Scnn1b-Tg+ mice 
(Figure 7), supporting the hypothesis that mucus stasis per se can lead to inflammation by 
trapping non-infectious, noxious materials.
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As LPS levels were minimal in the GF environment (Figure 8b), we speculate that other 
stimuli contributed to macrophage activation (Figure 7i) and neutrophil recruitment (Figure 
7f) in GF Scnn1b-Tg+ mice. Beside inhaled noxious stimuli, necrotic bronchial epithelial 
cells transiently present in 3 day-old Scnn1b-Tg+ mice 3 could also contribute to the sterile 
inflammation observed in Scnn1b-Tg+ mice. We speculate that once initiated by poor 
clearance of toxic materials, the inflammatory process is perpetuated by the retention of 
stimuli causing macrophage activation and the sequelae of neutrophil recruitment, including 
secondary necrosis 38 and release of other chemoattractants, e.g., high-mobility group box 1 
and PGP 39.
Additional features of mice reared in the GF environment were noted. GF mice still exhibit 
the transient neonatal surge in mucous secretory cells and eosinophils described for SPF 
mice 8 (Figure 7d,g). Furthermore, neonatal GF WT mice had fewer neutrophils (Figure 7f) 
than neonatal SPF WT mice (Figure 2b), consistent with the notion that normal airways may 
not be completely sterile and intrapulmonary bacteria help guide immune development 40. 
Indeed, the absence of environmental bacteria might affect the overall immune response to 
airway mucus stasis, as suggested by the higher number of macrophages recovered in 
neonatal GF vs. SPF Scnn1b-Tg+ mice (Figures 7e and 2a). Finally, both SPF and GF 
Scnn1b-Tg+ mice develop bronchial-associated lymphoid tissue (BALT) (Figure 7d and 8), 
which is usually thought to result from TLR stimulation 41 and whose incidence correlates 
with worsening airflow obstruction in COPD patients 42. The observation that both 
MyD88−/−; Scnn1b-Tg+ mice and GF Scnn1b-Tg+ mice exhibit lymphoid aggregates 
suggests that neither MyD88 signaling nor bacterial stimulation is required for this response 
in the context of airway mucus stasis.
The hypothesis that CF is characterized by intrinsic lung inflammation in the absence of 
bacterial infection is controversial 43,44, and novel animal models have been generated to 
better understand the critical phases of disease onset and progression 45,46. Although we did 
not perform BAL studies on prenatal Scnn1b-Tg+ mice, whose airways are not exposed to 
bacteria or bacterial products, previous studies reported that the concentration of KC and 
MIP-2 in lung homogenates from newborn (PND 1) Scnn1b-Tg+ mice was not different 
from WT littermates 2, whereas an inflammatory infiltrate was clearly present in Scnn1b-
Tg+ mice just a few days later (PND3), in conjunction with tracheal mucus plugging 3,47, 
suggesting that the inflammatory response develops as a consequence of airway mucus 
obstruction. Collectively, our data from the GF and SPF Scnn1b-Tg+ mice suggest that 
mucus stasis per se produces airway inflammation and that mucus stasis results in 
susceptibility to infection by bacteria aspirated from the oropharynx. Due to its unique 
phenotype and the amenability to complex genetic and environmental manipulations, the 
Scnn1b-Tg+ mouse model has allowed us to probe the interactions of abnormal mucus 
clearance and other layers of lung defense, e.g., MyD88-dependent pathways. Our data 
suggest that stagnant mucus can initiate both the inflammatory and infectious components of 
obstructive lung diseases and thus, is a primary therapeutic target. As such, therapies aimed 
at promoting mucus clearance would provide three interconnected benefits, namely to 
alleviate inflammation, eradicate infection, and restore immune homeostasis.
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Mice were housed in a specific pathogen free (SPF) facility at the University of North 
Carolina at Chapel Hill. Congenic C57Bl6/N Scnn1b-Tg+ mice were generated by 
backcrossing C3:B6 Scnn1b-Tg+ mice line 6608 2 with C57Bl/6N mice (Taconic, Hudson, 
NY) for more than 12 generations. Mice were housed in hot-washed, individually ventilated 
micro-isolator cages with corn cob bedding, on a 12-hour day/night cycle, fed regular chow 
and given water ad libitum. MyD88−/− mice [B6.129P2-Myd88tm1Aki 48, kindly provided by 
Dr. Shizuo Akira, Osaka University, through Dr. Jonathan Serody, University of North 
Carolina at Chapel Hill] were bred with C57Bl6 Scnn1b-Tg+ mice to obtain experimental 
animals of four predicted genotypes with expected Mendelian distribution of 25% each: 
MyD88+/−;Scnn1b-Tg-, MyD88−/−;Scnn1b-Tg-, MyD88+/−;Scnn1b-Tg+, and 
MyD88−/−;Scnn1b-Tg+. This breeding strategy generated control mice heterozygous for 
MyD88, which were not expected to be different from MyD88+/+ mice, and gave the 
advantage that experimental animals of all four genotypes were littermates and shared an 
identical environment. Our first attempt to establish this colony and monitor survival by 
early toe excision (PND 2–3) was unsuccessful as MyD88−/− mice rapidly died, likely due 
to susceptibility to infection after early toeing. To increase survival, breeder pairs were 
housed in “cleaner conditions”, i.e., cages with autoclaved TEK-FRESH bedding (Harlan) 
changed weekly, and were given autoclaved food and antibiotic-supplemented water 
(sulfamethoxazole 0.64 mg/ml and trimethoprim, 0.13 mg/ml) until the dams gave birth. 
Pups were toed for identification and genotyping at PND 5. Germ-free Scnn1b-Tg+ mice 
were generated in the National Gnotobiotic Rodent Resource Center at UNC. Germ-free 
rodents are axenic, with no detectable bacteria, yeast, molds, parasites or viruses (except 
retroviruses). To monitor the sterility of the isolator containing the GF Scnn1b-Tg+ mouse 
colony, samples of fresh feces, mouth/paws/cages swabs, and drinking water were collected 
from breeders and holding mice every time the port was open. Collected samples were tested 
for the presence of contaminating bacteria by plating onto sheep blood agar, growth in fluid 
thioglycollate medium (FTG), and Gram staining. Regardless of port opening, all isolators 
were periodically monitored (every other month) through Gram staining and 16S PCR on 
sampled feces. The isolator containing the GF Scnn1b-Tg+ mice colony never suffered a 
breach in germ-free status, and we studied mice from different litters at different ages, over a 
several months period. All animal studies were approved by the Institutional Animal Care 
and Use Committee of the University of North Carolina at Chapel Hill and performed 
according to the principles outlined by the Animal Welfare and the National Institutes of 
Health guidelines for the care and use of animals in biomedical research.
Bronchoalveolar lavage (BAL), differential cell counts, lung histology, and macrophage 
size
For 10 day-old or older mice, we obtained both BAL and lung histology from each animal, 
as previously described 8. Due to their small size, 5 day-old pups were subject to either 
whole lung BAL or tissue harvesting. Macrophage size was determined by measuring the 
surface area of 60–80 macrophages/mouse. Cytospin preparations were photographed with a 
Leica DMIRB inverted microscope interfaced with a Micro Publisher 3.3 color camera (Q-
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Imaging, Surrey, BC, Canada) at 20× magnification and macrophage area was determined 
using the calibrated freehand selection tool of Image J analysis software (NIH, Bethesda). 
Histology specimens were scored by an investigator blinded to genotype using a semi-
quantitative scoring system, as described previously 8.
Cytokine profile
Mouse TNFα, KC, MIP-2, MIP-1α, M-CSF, MCP-1, LIX, IL-6, IL-1α, IL-1β, GM-CSF, 
and G-CSF were measured in cell-free BAL using a Luminex-based assay (EMD Millipore, 
Billerica, MA), according to the manufacturer instructions.
Bacteriology
BAL was performed aseptically, inserting the cannula by tracheotomy in the lower portion 
of the trachea, to avoid oropharyngeal bacteria. Whole lungs were lavaged 4 times, using a 
weight-based formula 8 and fractions pooled. Serial BAL dilutions were plated onto 
Columbia anaerobe sheep blood agar (Becton Dickinson, NJ) and incubated in a candle jar 
to facilitate the growth of microaerophilic bacteria. Plates were incubated at 37°C for 24 
hours, and colony forming units (CFU) were enumerated and classified based on their 
morphology. Individual colonies representative of each morphologic group were expanded 
and processed for molecular identification. For detection of bacteria in tissue homogenates, 
tongue, esophagus, trachea and lungs were dissected from 5 day-old mice and homogenized 
in 1 ml of sterile Dulbecco’s phosphate-buffered saline (D-PBS, Sigma, MO) using a Tissue 
Tearor (Biospec products, OK) on ice. Serial dilutions were plated and processed as 
described above.
Molecular identification of bacterial species
Bacterial DNA was extracted using the FastDNA SPIN Kit, lysing Matrix B protocol (MP 
Biomedicals, OH), according to manufacturer’s instructions. The ribosomal 16S gene was 
amplified by PCR using HPLC-purified primers (forward 5′ AGAGTTTGATC(A + 
C)TGGCTCAG 3′, reverse 5′ TACGG(C+T)TACCTTGTTACGACTT 3′) and the 
following PCR conditions: denaturing 95°C for 5 min; 35 cycles of amplification (95°C for 
20 sec, 51°C for 20, 72°C for 1 min and 10 sec); 72°C for 8 min. Primers and dNTPs were 
removed from the PCR product by digestion with exonuclease I and shrimp alkaline 
phosphatase (ExoSAP-IT, USB Corp., OH). The PCR product was sequenced using both 
forward and reverse primers (Genewiz, NJ). Bacterial identities were inferred from the 
degree of alignment of the ribosomal 16S gene sequences with existing databases (NCBI 
Nucleotide collection, excluding “models” and “uncultured/environmental sample 
sequences”), using the NCBI Basic Local Alignment Search Tool (BLAST).
LPS assay
Limulus amebocyte lysate assay was performed on unfractionated BAL from 5 day-old WT 
and Scnn1b-Tg+ mice using the Pyrochrome kinetic method, according to manufacturer 
instructions (Associates of Cape Cod, Inc. MA). The assay was performed under conditions 
that allowed cumulative detection of both LPS and β-glucan.
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Estimate of mucus volume
Mucus volume was calculated from the adult mouse ASL volume of 2.27 μl 49 and the 
adult/pup scaling factor of 2, obtained by dividing the average tracheal length or diameter in 
20 g vs. 3 g mice. Measurements were courtesy of Dr. Barbara Grubb, UNC Chapel Hill.
Statistical analyses
Statistical analyses were performed using SigmaStat 3.1 or JMP 8.0.2. Survival curves were 
compared using Kaplan-Meier log rank analysis and Holm-Sidak multiple comparison. All 
numeric values were log10 transformed with an offset of +1 before inferential statistical 
analyses. Comparisons between measurements from 2 groups with significant difference in 
variances were performed using Student t test assuming non-equal variance, or non-
parametric Wilcoxon rank-sum test. Comparison between multiple groups were performed 
using one-way analysis of variance (ANOVA) and differences among the group means were 
assessed by Tukey-Kramer post-hoc test for multiple test correction. For inferential 
statistics, p<0.05 was considered statistically significant and “n” represents the number of 
animals in each experimental group. Data presented in plots with error bars are expressed as 
mean ± SEM. Distribution of macrophage sizes between control (WT or MyD88+/−;Scnn1b-
Tg-) and test groups were performed by determining the 90% threshold in the control group, 
and comparing the proportion of cells in the test group beyond the threshold. Statistical 
significance between the proportions of cells that passed the threshold in the test group vs. 
control group (10%) was evaluated using χ2 test.
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Figure 1. Spontaneous bacterial colonization in C57BL/6N Scnn1b-Tg+ mice
(a) Timecourse analysis of total colony forming units (CFU) in BAL samples from Scnn1b-
Tg+ mice (■) and WT littermates (□). (Log10+1)-transformed data. n= number of mice/
group. T test ** p<0.005, * p<0.05 vs. WT littermates. (b) Individual CFUs and bacterial 
species isolated from C57BL/6N Scnn1b-Tg+ mice. Each tick on the x axis represents an 
individual mouse. (c) Bacteria isolated from tongue, esophagus, trachea, and lung tissue 
homogenates of PND 5 C57BL/6N Scnn1b-Tg+ mice and WT littermates. (Log10+1)-
transformed data. Each tick on the x axis represents an individual mouse. CFUs in confluent 
plates could not be enumerated and were arbitrarily set at 2×107 CFU/tissue.
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Figure 2. Developmental profile of lung inflammation in C57BL/6N Scnn1b-Tg+ mice
(a-d). Longitudinal BAL cell counts in Scnn1b-Tg+ mice (■) and WT littermates (□). n= 6 
and 8 at 5 days (5d); n= 7 and 12 at 10 days (10d); n=12 and 13 at 4 weeks (4wk); n=10 and 
8 at 8 weeks (8wk); n=4 and 4 at 6 months (6mo); n=14 and 6 at 12 months (12mo), for WT 
and Scnn1b-Tg+, respectively. (e-f) Longitudinal KC and TNFα levels in BAL fluid. n= 4 
WT and 6 Scnn1b-Tg+ mice. T test ** p<0.005, * p<0.05 vs. WT littermates. (g–h) 
Macrophage size distribution in 5 day and 4 week-old C57BL/6N Scnn1b-Tg+ mice and WT 
littermates. n= 6 WT and 8 Scnn1b-Tg+ mice at PND 5; 10 WT and 13 Scnn1b-Tg+ mice at 
PND 28. Boxed regions highlight the percentage of total macrophages larger than the 90th 
percentile in WT mice. T test ** p<0.005, * p<0.05 vs. WT littermates.
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Figure 3. Genetic deletion of MyD88 decreases neonatal survival and increases lung bacterial 
burden in WT and Scnn1b-Tg+ mice
(a) Survival curves. Absence of MyD88 in Scnn1b-Tg+ mice lowers survival. ANOVA * p = 
0.004 vs. littermates. (b) Representative photomicrograph of BAL cytospin preparations 
from neonatal MyD88-sufficient and -deficient Scnn1b-Tg+ mice, illustrating mucus-
associated bacteria in MyD88−/−;Scnn1b-Tg+ mice. Scale bar = 10 μm. (c) Bacterial CFU in 
mice from the MyD88−/− × Scnn1b-Tg+ cross at the ages indicated, (Log10+1)-transformed 
data. n= number of mice/group. ANOVA ** p<0.005, * p<0.05 vs. MyD88+/−;Scnn1b-Tg− 
mice. # p<0.05 vs. MyD88+/−;Scnn1b-Tg+ mice. (d) Lung microflora in mice from the 
MyD88−/− × Scnn1b-Tg+ cross. Each tick on the x axis represents an individual mouse.
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Figure 4. Genetic deletion of MyD88 reduces lung neutrophilia in Scnn1b-Tg+ mice, but does not 
blunt macrophage activation
(a–d) Differential BAL cell counts. n= 8, 9, 8, 8 at 5 days (5d), n= 14, 9, 12, 12 at 10 days 
(10d), n= 5, 5, 5, 9 at 4 weeks (4wk), and n= 3, 6, 7, 8 at 8 weeks (8wk) for 
MyD88+/−;Scnn1b-Tg-, MyD88−/−;Scnn1b-Tg-, MyD88+/−;Scnn1b-Tg+, and 
MyD88−/−;Scnn1b-Tg+ mice, respectively. ANOVA ** p<0.005, * p<0.05 vs. 
MyD88+/−;Scnn1b-Tg− mice. # p<0.05 vs. MyD88+/−;Scnn1b-Tg+ mice. (e) Macrophage 
size distribution in 4 week-old mice from the MyD88−/− × Scnn1b-Tg+ cross. Boxed regions 
highlight the percentage of total macrophages larger than the 90th percentile in 
MyD88+/−;Scnn1b-Tg− mice. n=5 MyD88+/−;Scnn1b-Tg-, 4 MyD88−/−;Scnn1b-Tg-, 5 
MyD88+/−;Scnn1b-Tg+, and 8 MyD88−/−;Scnn1b-Tg+. ANOVA ** p<0.005, * p<0.05 vs. 
MyD88+/−;Scnn1b-Tg-littermates.
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Figure 5. MyD88 deletion in Scnn1b-Tg+ mice alters BAL neutrophil- and macrophage-related 
inflammatory mediators
BAL cytokines in 5 day-, 10 day- and 4 week-old mice. The dotted line represents the assay 
lower detection limit (LOD). n = 4 for WT mice and n=6 for Scnn1b-Tg+ mice. ANOVA ** 
p<0.005, * p<0.05 vs. age-matched MyD88+/−;Scnn1b-Tg− mice. # p<0.05 vs. 
MyD88+/−;Scnn1b-Tg+ mice.
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Figure 6. MyD88 deletion does not modify mucus plugging, but promotes development of 
lymphoid aggregates in Scnn1b-Tg+ mice
(a-c)Semi-quantitative histopathology scores for mucus plugs and mucous secretory cells 
(AB-PAS positive) in (a) neonatal trachea and (b-c) left lobe intrapulmonary main stem 
bronchus, at different time points. (d) Semi-quantitative histopathology scores for lymphoid 
aggregates (BALT). n= 6, 8, 3, 5 at 1–3 days (1–3d), n= 5, 6, 4, 8 at 5 days (5d), n= 13, 5, 
10, 12 at 10 days (10d), n= 5, 4, 5, 9 at 4 weeks (4wk), and n= 8, 8, 11, 9 at 8 weeks (8wk) 
for MyD88+/−;Scnn1b-Tg-; MyD88−/−;Scnn1b-Tg-; MyD88+/−;Scnn1b-Tg+; and 
MyD88−/−;Scnn1b-Tg+ mice, respectively. ANOVA ** p<0.005, * p<0.05 vs. 
MyD88+/−;Scnn1b-Tg− mice. # p<0.05 vs. MyD88+/−;Scnn1b-Tg+ mice.
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Figure 7. Germ-free (GF) Scnn1b-Tg+ mice develop lung inflammation similar to Scnn1b-Tg+ 
mice raised in conventional SPF conditions
(a, b) Representative photomicrographs of left lobe main stem bronchus from 6 week-old 
GF Scnn1b-Tg+ mice, illustrating alveolar space enlargement, mucus obstruction, and 
airway inflammation. H&E (a) and AB-PAS (b) stain. Scale bar 100 μm. (c) Representative 
photomicrograph of BAL cytospin preparation from GF Scnn1b-Tg+ mice, illustrating 
mucus plugs (light blue), granulocytes and large/foamy macrophages (arrows). Giemsa 
stain, scale bar = 20 μm. (d) Semi-quantitative histopathology scores for 10 day old (10 d, 
open bars) and 4 week-old (4 wk, hatched bars) Scnn1b-Tg+ mice (gray) and WT littermates 
(white) raised in GF conditions, n= 11 Scnn1b-Tg+ and 11 WT littermates at 10 days, n=7 
Scnn1b-Tg+ and 9 WT littermates at 4 weeks of age. T test ** p<0.005, * p<0.05 vs. WT 
littermates. (e-h) Longitudinal differential BAL cell counts for GF Scnn1b-Tg+ mice (■) 
and WT littermates (□). n= 11 and 11 at 5 days, n= 18 and 8 at 10 days, n= 8 and 7 at 4–7 
weeks, for GF WT and GF Scnn1b-Tg+ mice, respectively. (i) Macrophage size distribution 
in 4–7 week-old GF Scnn1b-Tg+ mice (■, n=7) and WT littermates (□, n=8). Boxed regions 
highlight the percentage of total macrophages larger than the 90th percentile in WT mice. T 
test ** p<0.005 vs. WT littermates.
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Figure 8. BAL cytokine profile and BAL LPS content in germ-free Scnn1b-Tg+ mice and WT 
littermates
(a) BAL cytokines in 5 day-, 10 day- and 6 week-old mice. The dotted line represents the 
assay lower detection limit (LOD). n = 6 for WT and 8 for Scnn1b-Tg+ mice. ANOVA ** 
p<0.005, * p<0.05 vs. WT littermates. (b) LPS content in BAL isolated from SPF or GF 
Scnn1b-Tg+ mice (■) and WT littermates (□). n= 14 and 11 for SPF WT and Scnn1b-Tg+ 
mice, respectively; n= 4 and 5 for GF WT and Scnn1b-Tg+ mice, respectively. T test * 
p<0.05 vs. WT littermates.
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